Myriad Genetics Inc (MYGN)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt MYGN? Forum Prognose Aktiensplit

Finanzdaten der Myriad Genetics Inc-Aktie (MYGN)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	8.78% 213.10	195.90	210.60	213.30	211.50
Cost Of Revenue	0.65% 61.30	61.70	59.70	63.50	64.40
Gross Profit	13.11% 151.80	134.20	150.90	149.80	147.10
Operating Expenses	194.73% 481.00	163.20	189.90	169.80	183.60
Benefits Costs and Expenses	141.32% 543.70	225.30	249.70	234.50	248.70
Costs And Expenses	141.32% 543.70	225.30	249.60	233.30	248.00
Depreciation and Amortization	2.08% 14.10	14.40	14.80	15.60	15.10
Operating Income/Loss	1,035% -329.20	-29.00	-39.00	-20.00	-36.50
Nonoperating Income/Loss	250.00% -1.40	-0.40	-0.10	-1.20	-0.70
Income/Loss From Continuing Operations Before Tax	1,024% -330.60	-29.40	-39.10	-21.20	-37.20
Income Tax Expense/Benefit	99.66% -0.10	-29.30	3.40	0.90	-0.50
Income/Loss From Continuing Operations After Tax	330.40K% -330.50	-0.10	-42.50	-22.10	-36.70
Net Income/Loss	330.40K% -330.50	-0.10	-42.50	-22.10	-36.70
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	1.20% 92.50	91.40	0.10	90.90	90.60
Diluted Average Shares	1.20% 92.50	91.40	0.10	90.90	90.60
Basic Earnings Per Share	-3.57	-	-0.47	-0.24	-0.41
Diluted Earnings Per Share	-3.57	-	-0.47	-0.24	-0.41
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

WAT

$299.69

3.32%

DGX

$180.11

0.33%

NTRA

$166.56

0.58%

$275.23

0.51%

MTD

$1,287.79

1.51%

IQV

$184.08

0.29%